Increased 𝜶-Fetoprotein Predicts Steatosis among Patients with Chronic Hepatitis C Genotype 4

Table 1

Clinical, biochemical and histopathological characteristics of patients with and without steatosis.

	Steatosis + VE	Steatosis − VE	𝑃 value
Age (years)	41.62±6.37	43.68±6.94	0.126
Grade (Ishak grading)	5.90±2.21	2.48±.1.50	0.001*
Stage of fibrosis (Ishak staging)	2.72±1.93	.50±.50	0.001*
AFP (ng/mL)	8.64±3.18	3.56±.81	0.001*
Triglyceride (mg/dL)	108.95±26.39	102.68±31.65	0.323
FB glucose (mg/dL)	106.76±75.84	101.31±14.35	0.44
Alumin (g/dL)	4.40±.30	4.50±.28	0.115
AST (u/L)	53.62±20.83	34.42±15.26	0.001*
ALT (u/L)	57.72±20.43	45.22±18.47	0.002*
Total Bilirubin (mg/dL)	0.82±.35	0.62±.34	0.023*
Prothrombin time concentration %	88.09±7.39	84.50±3.64	0.003*
BMI	29.3±5.2	28.9±3.2	0.695
HCV RT-RNA (IU/mL)	224529.1±308275.96	298415.9±320004.30	0.302

AFP, Alpha-fetoprotein; FB glucose, Fasting blood glucose; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BMI, body mass index; RT-PCR, reverse transcriptase-polymerase chain reaction.